Goldman Sachs’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-658
| Closed | -$12K | – | 5433 |
|
|
2022
Q3 | $12K | Sell |
658
-8,824
| -93% | -$161K | ﹤0.01% | 5249 |
|
|
2022
Q2 | $211K | Buy |
9,482
+1,090
| +13% | +$24.3K | ﹤0.01% | 4878 |
|
|
2022
Q1 | $233K | Buy |
8,392
+41
| +0.5% | +$1.14K | ﹤0.01% | 5019 |
|
|
2021
Q4 | $379K | Buy |
8,351
+3,152
| +61% | +$143K | ﹤0.01% | 4671 |
|
|
2021
Q3 | $434K | Buy |
5,199
+4,096
| +371% | +$342K | ﹤0.01% | 4460 |
|
|
2021
Q2 | $105K | Sell |
1,103
-4,302
| -80% | -$410K | ﹤0.01% | 5107 |
|
|
2021
Q1 | $899K | Buy |
+5,405
| New | +$899K | ﹤0.01% | 3986 |
|
|
2019
Q3 | – | Sell |
-670
| Closed | -$89K | – | 4359 |
|
|
2019
Q2 | $89K | Buy |
670
+286
| +74% | +$38K | ﹤0.01% | 4014 |
|
|
2019
Q1 | $64K | Sell |
384
-187
| -33% | -$31.2K | ﹤0.01% | 4064 |
|
|
2018
Q4 | $62K | Buy |
571
+401
| +236% | +$43.5K | ﹤0.01% | 3953 |
|
|
2018
Q3 | $37K | Buy |
170
+97
| +133% | +$21.1K | ﹤0.01% | 4042 |
|
|
2018
Q2 | $157K | Sell |
73
-254
| -78% | -$546K | ﹤0.01% | 3934 |
|
|
2018
Q1 | $812K | Buy |
+327
| New | +$812K | ﹤0.01% | 3278 |
|
|
2016
Q4 | – | Sell |
-33
| Closed | -$36K | – | 4594 |
|
|
2016
Q3 | $36K | Sell |
33
-5
| -13% | -$5.46K | ﹤0.01% | 4358 |
|
|
2016
Q2 | $29K | Buy |
38
+24
| +171% | +$18.3K | ﹤0.01% | 4350 |
|
|
2016
Q1 | $10K | Sell |
14
-4
| -22% | -$2.86K | ﹤0.01% | 4438 |
|
|
2015
Q4 | $17K | Buy |
18
+4
| +29% | +$3.78K | ﹤0.01% | 4361 |
|
|
2015
Q3 | $14K | Sell |
14
-10
| -42% | -$10K | ﹤0.01% | 4494 |
|
|
2015
Q2 | $49K | Hold |
24
| – | – | ﹤0.01% | 4430 |
|
|
2015
Q1 | $23K | Sell |
24
-7
| -23% | -$6.71K | ﹤0.01% | 4399 |
|
|
2014
Q4 | $32K | Sell |
31
-32
| -51% | -$33K | ﹤0.01% | 4445 |
|
|
2014
Q3 | $65K | Sell |
63
-16
| -20% | -$16.5K | ﹤0.01% | 4334 |
|
|
2014
Q2 | $153K | Buy |
79
+15
| +23% | +$29.1K | ﹤0.01% | 4089 |
|
|
2014
Q1 | $136K | Buy |
64
+3
| +5% | +$6.38K | ﹤0.01% | 4070 |
|
|
2013
Q4 | $140K | Buy |
61
+31
| +103% | +$71.1K | ﹤0.01% | 4007 |
|
|
2013
Q3 | $86K | Buy |
30
+1
| +3% | +$2.87K | ﹤0.01% | 4040 |
|
|
2013
Q2 | $264K | Buy |
+29
| New | +$264K | ﹤0.01% | 3499 |
|